A technique for the transfer of endothelial cells and expression of recombinant genes in vivo could allow the introduction of proteins of therapeutic value in the management of cardiovascular diseases. Porcine endothelial cells expressing recombinant β-galactosidase from a murine amphotropic retroviral vector were introduced with a catheter into denuded iliofemoral arteries of syngeneic animals. Arterial segments explanted 2 to 4 weeks later contained endothelial cells expressing β-galactosidase, an indication that they were successfully implanted on the vessel wall.
|Original language||English (US)|
|Number of pages||3|
|State||Published - 1989|
ASJC Scopus subject areas